Integrating clinical, molecular, proteomic and histopathological data within the tissue context: tissunomics

Santiago Ramón y Cajal, Stefan Hümmer, Vicente Peg, Xavier M. Guiu, Inés De Torres, Josep Castellvi, Elena Martinez-Saez, Javier Hernandez-Losa

Producción científica: Contribución a una revistaArtículo de revisiónInvestigaciónrevisión exhaustiva

6 Citas (Scopus)

Resumen

© 2019 Authors. Histopathology Published by John Wiley & Sons Ltd Malignant tumours show a marked degree of morphological, molecular and proteomic heterogeneity. This variability is closely related to microenvironmental factors and the location of the tumour. The activation of genetic alterations is very tissue-dependent and only few tumours have distinct genetic alterations. Importantly, the activation state of proteins and signaling factors is heterogeneous in the primary tumour and in metastases and recurrences. The molecular diagnosis based only on genetic alterations can lead to treatments with unpredictable responses, depending on the tumour location, such as the tumour response in melanomas versus colon carcinomas with BRAF mutations. Therefore, we understand that the correct evaluation of tumours requires a system that integrates both morphological, molecular and protein information in a clinical and pathological context, where intratumoral heterogeneity can be assessed. Thus, we propose the term ‘tissunomics’, where the diagnosis will be contextualised in each tumour based on the complementation of the pathological, molecular, protein expression, environmental cells and clinical data.
Idioma originalInglés
Páginas (desde-hasta)4-19
PublicaciónHistopathology
Volumen75
N.º1
DOI
EstadoPublicada - 1 jul 2019

Huella

Profundice en los temas de investigación de 'Integrating clinical, molecular, proteomic and histopathological data within the tissue context: tissunomics'. En conjunto forman una huella única.

Citar esto